BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 15688309)

  • 1. Drug resistance and fitness in Mycobacterium tuberculosis infection.
    Bottger EC; Pletschette M; Andersson D
    J Infect Dis; 2005 Mar; 191(5):823-4; author reply 824. PubMed ID: 15688309
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular mechanisms of the formation of drug resistance of Mycobacterium tuberculosis (review of the literature)].
    Tungusova OS; Mar'iandyshev AO
    Probl Tuberk; 2001; (6):48-9. PubMed ID: 11641963
    [No Abstract]   [Full Text] [Related]  

  • 3. [Impact of drug resistance on the fitness of Mycobacteruim tuberculosis of the genotype W-Beijing].
    Tungusova OS; Mar'iandyshev AO; Kaugant DA; Sandven P; Bjeune G
    Probl Tuberk Bolezn Legk; 2005; (8):46-50. PubMed ID: 16209021
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
    Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterisation of isoniazid-resistant Mycobacterium tuberculosis isolated from new cases in Lagunes region (Côte d'Ivoire).
    N'Guessan KR; Dosso M; Ekaza E; Kouakou J; Jarlier V
    Int J Antimicrob Agents; 2008 May; 31(5):498-500. PubMed ID: 18313272
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug resistance characterization on Beijing family of Mycobacterium tuberculosis].
    Guo YL; Liu Y; Wang SM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):306-7. PubMed ID: 19642395
    [No Abstract]   [Full Text] [Related]  

  • 7. [Molecular-genetic method of identification of drug-resistant Mycobacterium tuberculosis].
    Dubileĭ SA; Ignatova AN; Shemiakin IG
    Mol Gen Mikrobiol Virusol; 2005; (1):3-7. PubMed ID: 15790026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular snapshot of drug-resistant and drug-susceptible Mycobacterium tuberculosis strains circulating in Bulgaria.
    Valcheva V; Mokrousov I; Narvskaya O; Rastogi N; Markova N
    Infect Genet Evol; 2008 Sep; 8(5):657-63. PubMed ID: 18657631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in genes associated with drug resistance in Mycobacterium tuberculosis isolates from Italy.
    Musser JM; Amin A; Ramaswamy S
    J Infect Dis; 1999 Nov; 180(5):1751-3. PubMed ID: 10515850
    [No Abstract]   [Full Text] [Related]  

  • 10. Genotypic and phenotypic resistance of Mycobacterium tuberculosis to rifamycins and fluoroquinolones.
    Yew WW; Chan E; Chan CY; Cheng AF
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):936-7. PubMed ID: 12365583
    [No Abstract]   [Full Text] [Related]  

  • 11. Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis.
    de Steenwinkel JE; de Knegt GJ; ten Kate MT; van Belkum A; Verbrugh HA; Kremer K; van Soolingen D; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2010 Dec; 65(12):2582-9. PubMed ID: 20947621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates.
    Soudani A; Hadjfredj S; Zribi M; Masmoudi A; Messaoud T; Tiouri H; Fendri C
    J Clin Microbiol; 2007 Sep; 45(9):3095-7. PubMed ID: 17652484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA.
    Leung ET; Ho PL; Yuen KY; Woo WL; Lam TH; Kao RY; Seto WH; Yam WC
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1075-8. PubMed ID: 16495272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the role of Mycobacterium tuberculosis kasA gene mutations in isoniazid resistance.
    Sun YJ; Lee AS; Wong SY; Paton NI
    Clin Microbiol Infect; 2007 Aug; 13(8):833-5. PubMed ID: 17501974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the CombiChip Mycobacteria Drug-Resistance detection DNA chip for identifying mutations associated with resistance to isoniazid and rifampin in Mycobacterium tuberculosis.
    Kim SY; Park YJ; Song E; Jang H; Kim C; Yoo J; Kang SJ
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):203-10. PubMed ID: 16458476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis.
    Palomino JC; Martin A; Von Groll A; Portaels F
    J Microbiol Methods; 2008 Oct; 75(2):161-6. PubMed ID: 18627779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular epidemiology of ethambutol-resistant Mycobacterium tuberculosis in Henan Province, China.
    Sugawara I; Otomo K; Yamada H; Wang G; Du C; Shi R; Zhang G
    Jpn J Infect Dis; 2005 Dec; 58(6):393-5. PubMed ID: 16377878
    [No Abstract]   [Full Text] [Related]  

  • 18. Tuberculosis. Few mutations divide some drug-resistant TB strains.
    Koenig R
    Science; 2007 Nov; 318(5852):901-2. PubMed ID: 17991835
    [No Abstract]   [Full Text] [Related]  

  • 19. Transmission of isoniazid-resistant tuberculosis.
    Borgdorff MW
    J Infect Dis; 2004 Aug; 190(3):650; author reply 650-1. PubMed ID: 15243944
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection and evaluation of the mutations of embB gene in ethambutol-susceptible and resistant Mycobacterium tuberculosis isolates from China.
    Wu XQ; Liang JQ; Zhang JX; Lu Y; Li HM; Zhang GY; Yan GR; Ding BC
    Chin Med J (Engl); 2005 Oct; 118(20):1739-41. PubMed ID: 16313761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.